Tailored Viral Vector Solutions
Overcome Challenges in Viral Vector Therapy Development with an Experienced Partner on Your Side
Gene therapies are a growing class of therapeutics with the potential to transform lives. However, we understand the challenges posed when attempting to bring these therapies to market. We’ve stood side-by-side with thousands of clients, leveraging over 25 years of experience in the cell and gene therapy industry to support their programs from discovery to clinic and commercialization.
Through this experience, we’ve developed and refined a tailored offering to address the unique challenges of developing gene therapies, tackling challenges such as scalability, quality requirements and regulatory aspects.
Explore some of our tailored solutions
Small-scale cGMP services
Supporting early-phase studies and rare indications
We know that not every client working with viral vectors requires large-scale cGMP manufacturing. Our right-sized small-scale cGMP process complements our larger-scale offering by providing deliverables of 500mg or under, with the same cGMP oversight as our standard deliverables.
Standardized helper and packaging plasmids for AAV and lentivirus
Save money, time and streamline regulatory approval
Our off-the-shelf plasmids for viral vector development come with drug master files to expedite regulatory approval and have been used successfully in many programs. In addition, they are available in both research and clinical quality grades, with flexible sizes supporting both small- and large-scale studies.
GMP-Source™ manufacturing
Balance the needs of quality, cost, and timelines in early clinical stages
GMP-Source manufacturing for plasmid products retains many hallmarks of cGMP manufacture, while being designed to reduce timeframes and cost at early clinical stages.
Get started on your Viral Vector program today!
| region | na1 |
| portalId | 1769030 |
| formId | c799884c-a1bd-4948-8cfe-2cf904b67d66 |
| target | services-hubspot-form |